As of February 2026 Inhibrx Biosciences has a market cap of โน107.21 Billion. This makes Inhibrx Biosciences the world's 5701th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Feb 5th, 2026 the market cap of Inhibrx Biosciences was reported to be: